POEHLMANN_Supplementary_Figures_S1_and_S2 – Supplemental material for Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis

Pöhlmann, Johannes; Mitchell, Beth D.; Bajpai, Sanjay; Osumili, Beatrice; Valentine, William J.

doi:10.25384/SAGE.7661297.v1

POEHLMANN_Supplementary_Figures_S1_and_S2.pdf (58.78 kB)

POEHLMANN_Supplementary_Figures_S1_and_S2 – Supplemental material for Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis

journal contribution

posted on 2019-01-30, 12:00 authored by Johannes Pöhlmann, Beth D. Mitchell, Sanjay Bajpai, Beatrice Osumili, William J. Valentine

Supplemental material, POEHLMANN_Supplementary_Figures_S1_and_S2 for Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis by Johannes Pöhlmann, Beth D. Mitchell, Sanjay Bajpai, Beatrice Osumili and William J. Valentine in Journal of Diabetes Science and Technology